Compare TRX & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRX | PACB |
|---|---|---|
| Founded | 1990 | 2000 |
| Country | Canada | United States |
| Employees | N/A | 485 |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.0M | 419.8M |
| IPO Year | 2002 | 2010 |
| Metric | TRX | PACB |
|---|---|---|
| Price | $1.36 | $1.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $1.70 | ★ $2.10 |
| AVG Volume (30 Days) | 4.5M | ★ 4.7M |
| Earning Date | 04-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $93,468,000.00 |
| Revenue This Year | $73.52 | $11.22 |
| Revenue Next Year | $109.74 | $12.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $0.27 | $0.85 |
| 52 Week High | $2.80 | $2.73 |
| Indicator | TRX | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 39.40 | 41.30 |
| Support Level | $0.32 | $1.36 |
| Resistance Level | $1.95 | $1.51 |
| Average True Range (ATR) | 0.12 | 0.09 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 15.54 | 60.36 |
TRX Gold Corp is engaged in the exploration, development, and production of mineral property interests in the United Republic of Tanzania, focused on development and mining operations, and on exploring and evaluating its mineral properties. The business of exploring and mining for minerals involves a high degree of risk, and the underlying value of the mineral properties depends on the existence and economic recovery of mineral resources and reserves, as well as the ability to raise long-term financing to continue development. The company is focused on the Buckreef Gold Project, which comprises five prospects: Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba, and includes three main mineralized zones: Buckreef South, Buckreef Main, and Buckreef North.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.